TATucker Avra

Tucker Avra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tucker Avra has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Substance Use Disorder and Harm Reduction Curriculum in United States and Canadian Undergraduate Medical Education: An Online Survey

    by Tucker Avra, Andrew Nelson, Joseph Friedman, Willow Limbach, Mary Sarkisian, Tamiko Nesley, Tiffany Chu, Kyla Truman, Brandon Moghanian, Joshua Yazditabar, et al.

    Background: Substance use disorders (SUD) are a significant public health challenge, necessitating that clinicians are trained in SUD treatment and harm reduction (HR) strategies. Despite this, no studies have assessed the extent of SUD and HR training across all medical schools. This study assesses the current state of SUD and HR curriculum among medical students in the United States and Canada. Methods: From May to July 2023, we conducted an anonymous online survey via email invitation to student affairs’ offices of all 220 accredited US and Canadian medical schools. The survey assessed the curricula students were exposed to related to SUD treatment, HR, and stigmatizing attitudes. Results: A sample of 568 students from 52 medical schools (23.6% of all US and Canadian medical schools) completed the survey. Participants reported that in their medical school they were taught about: recognition of an opioid overdose (80.0%), identifying and treating opioid withdrawal (68.2%), principles and practices of HR (60.6%), administering naloxone (56.6%), the importance of syringe service programs (51.8%), prescribing methadone and/or buprenorphine (29.5%), and counseling patients on safe injection practices (11.4%). In addition, participants reported that they were taught: how to identify drug-seeking behavior (36.4%), that people who use heroin are “drug abusers” (24.4%), to withhold opioid pain medication from patients who are known or suspected to use drugs (15.9%), and that medication for opioid use disorder is another form of addiction (12.6%). Discussion: We found large curricular gaps related to the administration of medications for opioid use disorder and treating opioid overdose and withdrawal, as well as a significant prevalence of stigmatizing attitudes. Renewed efforts are needed to implement comprehensive and destigmatizing SUD curricula. The study is limited by response bias and is expected to overestimate the extent of HR related curriculum, indicating the true gap is likely higher than reported.


  • Off-label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report

    by Tucker Dvm Avra, Felipe Vasudevan, Rohit Mukherjee, Isabella Morton, Elizabeth A. Md Samuels

    Background: Ketamine is a dissociative anesthetic increasingly utilized in United States medical settings for the treatment of mental health conditions. Additionally, it is increasingly used in nonmedical settings for its dissociative properties. While nonmedical ketamine use and ketamine use disorder (KUD) have been observed internationally, KUD, and approaches to its treatment, have not been previously described in the US. Case Presentation: We present the case of a 32-year-old man with KUD who experienced severe cravings despite receipt of residential and intensive outpatient substance use disorder treatment. He resumed use after an initial period of abstinence and was subsequently started on lamotrigine and naltrexone for treatment of depressive symptoms and cravings. This combination altered his experience while on ketamine, resulting in nausea and decreased hallucinogenic effects. In addition, it substantially decreased his cravings, aiding him in achieving longer-term abstinence in combination with receipt of dialectical behavioral therapy, familial support, and involvement in 12-step programming. Discussion: KUD is a poorly described condition that may become more prevalent as US ketamine use increases. Combining treatment of depressive symptoms and cravings, in this case with lamotrigine and naltrexone, may be a promising pharmacotherapeutic strategy. Lamotrigine, an antiepileptic with glutamate modulating effects, has been utilized to decrease cravings in a variety of substance use disorders. Naltrexone is an opioid antagonist approved for alcohol use disorder and opioid use disorder and is used off-label for stimulant use disorder. This combination offers a possible pharmacotherapeutic option for KUD with more research needed to further evaluate.


  • Open Access

    Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study

    by Joseph Friedman, Morgan Godvin, Caitlin Molina, Ruby Romero, Annick Borquez, Tucker Avra, David Goodman-Meza, Steffanie Strathdee, Philippe Bourgois, Chelsea L. Shover


  • Readability assessment of online peripheral artery disease education materials

    by Tucker D. Avra, Monica Le, Stephanie Hernandez, Katie Thure, Jesus G. Ulloa


  • Case-control study to determine herd-level risk factors for bovine respiratory disease in nursing beef calves on cow-calf operations

    by Amelia R. Woolums, Roy D. Berghaus, David R. Smith, Russell F. Daly, Gerald L. Stokka, Brad J. White, Tucker Avra, Ali T. Daniel, Matt Jenerette

    OBJECTIVE To determine herd-level risk factors for bovine respiratory disease (BRD) in nursing beef calves. DESIGN Matched case-control study. SAMPLE 84 cow-calf operations in Nebraska, North Dakota, and South Dakota. PROCEDURES Case herds were herds that treated at least 5% of the calf crop for BRD prior to weaning. Control herds were herds that treated < 0.5% of the calf crop for BRD prior to weaning. Each case herd was matched with 2 control herds on the basis of veterinary practice and enrollment year. Herd owners or managers were interviewed by telephone, and characteristics and practices associated with case status were determined by multivariable conditional logistic regression. RESULTS 30 case herds and 54 control herds were evaluated. Increasing herd size, frequent pasture movement for intensive grass management (intensive grazing), and use of estrus-synchronization programs were significantly associated with herd status. The odds of being a case herd for herds with 150 to 499 cows was 7.9 times and that for herds with ≥ 500 cows was 12 times, compared with the odds of being a case herd for herds with < 150 cows. The odds of being a case herd for herds that used intensive grazing was 3.3 times that for herds that did not use intensive grazing. The odds of being a case herd for herds that used an estrus-synchronization program was 4.5 times that for herds that did not use an estrus-synchronization program. CONCLUSIONS AND CLINICAL RELEVANCE Management practices can be associated with an increase in the BRD incidence in nursing beef calves. Modification of management practices may decrease BRD incidence in nursing calves for herds in which it is a problem.


  • A retrospective analysis of risk factors associated with bovine respiratory disease treatment failure in feedlot cattle1

    by T. D. Avra, K. M. Abell, D. D. Shane, M. E. Theurer, R. L. Larson, B. J. White

    The objective of this project was to identify risk factors associated with the probability of failing to resolve clinical signs of bovine respiratory disease (BRD) after initial antimicrobial treatment. A retrospective data analysis was performed with 194,062 animals treated for BRD with an antimicrobial from 10 U.S. feedlots from 2005 to 2009. A binary variable classified cattle as a treatment failure if they were retreated for BRD or died following an initial BRD treatment. A generalized logistic mixed model was created to evaluate associations of quarter of the year at feedlot arrival, arrival weight, sex, risk classification (high vs. low), days on feed at first BRD treatment, and rectal temperature at first BRD treatment and all 2-way interactions with the probability of first treatment failure for BRD. A total of 64,683 out of 194,062 (33.3%) of cattle initially treated for BRD were classified as treatment failures due to death or retreatment. Multiple 2-way interactions were present. High-risk calves had greater probability of first treatment failure compared with low-risk calves, but this effect was modified by quarter of arrival, days on feed at first treatment, and rectal temperature category. The effect of arrival weight category was modified by days on feed at first treatment of BRD and quarter of arrival for probability of first treatment failure. Multiple arrival and treatment characteristics were associated with the probability of first BRD treatment failure. Knowledge of these factors can lead future prospective studies to improve the prediction of treatment failure and provide baseline results for the industry.


  • Open Access

    UCP1 in sebaceous glands corresponds with increased antioxidant potential and not brown adipose tissue function

    by Colette N. Miller, Ping Yu, Suresh Ambati, Elizabeth C. McKinney, Tucker Avra, Clifton A. Baile, Richard B. Meagher


  • Open Access

    A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats

    by Colette N. Miller, Jeong‐Yeh Yang, Tucker Avra, Suresh Ambati, Mary Anne Della‐Fera, Srujana Rayalam, Clifton A. Baile

    Objective: Menopausal reduction in estrogen causes increased adipose accumulation, leading many to turn to dietary supplements to prevent and treat such changes. Enhanced adipose mobilization stimulated by some supplements can increase the risk of non‐alcoholic fatty liver disease (NAFLD). Cytoprotective and anti‐obesity compounds may prevent the lipotoxicity associated with mobilization.Methods: A phytochemical blend was tested in aged, ovariectomized rats. Rats were given the AIN‐93M basal diet or a diet containing varying doses of phytochemicals with 2.4 IU/g vitamin D [diet 1: 1000 mg/kg genistein (G); diet 2: 500 mg/kg (G), 200 mg/kg resveratrol (R), and 1000 mg/kg quercetin (Q); diet 3: 1000 mg/kg (G), 400 mg/kg (R), and 2000 mg/kg (Q)].Results: Serum free fatty acids and hepatic triglycerides were elevated with diets 2 and 3. Despite this increase, the phytochemical blends did not increase apoptotic, cell repair, or remodeling gene expression. The highest phytochemical dose prevented increases in serum alanine aminotransferase.Conclusions: Adverse hepatic effects secondary to ovariectomy were mitigated through the inclusion of a dietary phytochemical blend in aged ovariectomized rats. The use of such compounds may not only help with weight management and disease risk in menopausal women, but may also prevent the lipotoxicity in NAFLD.